Low-density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy

Human Mutation

Volumn 19, Issue 5, 2002, Pages 560-569

  Waldmüller, Stephan ^a   Freund, Petra ^a   Mauch, Simon ^b   Toder, Roland ^b   Vosberg, Hans Peter ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b GeneScan Europe AG   (Germany)

Author keywords

CMH; DNA chips; Familial hypertrophic cardiomyopathy; Genetic testing; HCM; Microarray; Mutation detection; MYBPC3; MYH7; Myosin binding protein C; Myosin heavy chain 7; Reverse dot blot; TNNT2; TPM1; Tropomyosin, alpha; Troponin T2

Indexed keywords

DNA; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; NUCLEOTIDE; TROPOMYOSIN; TROPONIN T;

AMPLICON; ARTICLE; AUTOMATION; CAMERA; CONTROLLED STUDY; DENSITY; DNA HYBRIDIZATION; DNA MICROARRAY; DOT HYBRIDIZATION; EXON; FLUORESCENCE; GENE DELETION; GENE INSERTION; GENE MUTATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERTROPHIC CARDIOMYOPATHY; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; SCREENING;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; DNA; GENETIC SCREENING; HUMANS; MUTATION; MYOSIN HEAVY CHAINS; MYOSINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TROPOMYOSIN; TROPONIN T;

INSERTION SEQUENCES;

EID: 0036238517     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10074     Document Type: Article

References (25)

1. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
2. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy
3. Exploring the new world of the genome with DNA microarrays
4. An online locus-specific mutation database for familial hypertrophic cardiomyopathy
5. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation
6. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
7. A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: Application to quantitation of β-galactosidase in lacZ-transfected cells
8. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes
9. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays
10. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1)
11. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2)
12. Prevalence of hypertrophic cardiomyopathy in a population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study: Coronary artery risk development in (young) adults
13. Cardiovascular risks to young persons on the athletic field
14. DNA chips: An array of possibilities
15. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
16. Alteration of the relative stability of dA-dT and dG-dC base pairs in DNA
17. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance
18. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events
19. A sequencing method based on real-time pyrophosphate
20. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
21. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms
22. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies
23. The management of hypertrophic cardiomyopathy
24. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
25. Independent origin of identical beta cardiac myosin heavy chain mutations in hypertrophic cardiomyopathy